NDAORALTABLET
Approved
Nov 2018
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 43m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TEMIXYS is a fixed-dose combination oral tablet containing lamivudine and tenofovir disoproxil fumarate, nucleoside/nucleotide reverse transcriptase inhibitors used in antiretroviral therapy. This combination targets HIV-1 by inhibiting viral reverse transcriptase and is a cornerstone component of modern ART regimens. The product treats HIV-1 infection in treatment-naïve and treatment-experienced patients.
Peak
Product is at peak commercial maturity with moderate competitive pressure (30%), suggesting stable team size and focused optimization work rather than aggressive expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TEMIXYS offers stability in HIV therapeutics with exposure to global health, generic competition strategy, and emerging market dynamics. The zero linked job count and peak lifecycle stage suggest this is a maintenance-mode product requiring defensive commercial and access strategies rather than a growth opportunity.
Brand ManagerField Sales Representative
Worked on TEMIXYS at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.